CLEAR·OCEAN

Pfizer Inc. (PFE): insiders bought $1,959,190 in open-market purchases, SEC filings show

August 06, 2026 · Automated from SEC filings

2 insiders at Pfizer Inc. (PFE) reported open-market stock purchases totaling $1,959,190 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from BLAYLOCK RONALD E (director), who acquired 39,231 shares at $25.46 on August 05, 2026.

Reported open-market purchases

Source: SEC Form 4. Option grants and tax-withholding sales are excluded.

DateInsiderRoleSharesPriceValueSource
2026-08-05BLAYLOCK RONALD Edirector39,231$25.46$998,821SEC Form 4
2026-08-05Buckley Mortimer Jdirector37,632$25.52$960,369SEC Form 4

About the company

Pfizer Inc. is a Healthcare company in the Drug Manufacturers - General industry. It carried a market capitalization of about $147.1B, with shares trading near $25.81.

Sources

This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.